首页 | 本学科首页   官方微博 | 高级检索  
     

刺五加脑灵液联合扎来普隆治疗失眠症的临床研究
引用本文:钟晓波,范洁,曹水琴. 刺五加脑灵液联合扎来普隆治疗失眠症的临床研究[J]. 现代药物与临床, 2020, 35(2): 263-266
作者姓名:钟晓波  范洁  曹水琴
作者单位:成都市第四人民医院 精神科, 四川 成都 610036,成都市第四人民医院 精神科, 四川 成都 610036,成都市第四人民医院 精神科, 四川 成都 610036
摘    要:目的探讨刺五加脑灵液联合扎来普隆片治疗失眠症的临床疗效。方法选择2018年2月-2019年2月在成都市第四人民医院诊治的失眠症患者86例,根据用药的差别分为对照组(43例)和治疗组(43例)。对照组睡前口服扎来普隆片,5 mg/次,1次/d;治疗组在对照组的基础上口服刺五加脑灵液,10 mL/次,2次/d。两组患者均经10 d治疗。观察两组患者临床疗效,同时比较治疗前后两组患者PSQI、AIS、PHQ-9、WEMWBS和QLQ-C30评分,睡眠质量以及血清血清5-羟色胺(5-HT)、脑源性神经营养因子(BDNF)、白细胞介素-1β(IL-1β)、食欲素A(Orexin-A)、肿瘤坏死因子-α(TNF-α)和IL-2水平。结果治疗后,对照组临床有效率为81.40%,显著低于治疗组的97.67%,两组比较差异有统计学意义(P<0.05)。经治疗,两组患者PSQI评分、AIS评分和PHQ-9评分均显著降低(P<0.05),但WEMWBS评分和QLQ-C30评分均显著升高(P<0.05),且治疗组这些评分项目改善更明显(P<0.05)。经治疗,两组患者总睡眠时间、REM睡眠时间、睡眠效率均提高(P<0.05),而睡眠潜伏期、觉醒时间均显著缩短(P<0.05),且以治疗组改善最为明显(P<0.05)。经治疗,两组患者血清5-HT、BDNF水平均明显升高(P<0.05),但IL-1β、Orexin-A、TNF-α、IL-2水平均明显降低(P<0.05),且以治疗组改善最为明显(P<0.05)。结论刺五加脑灵液联合扎来普隆片治疗失眠症可显著改善睡眠情况,提高生活质量,有利于焦虑抑郁状态和心理健康状态改善。

关 键 词:刺五加脑灵液  扎来普隆片  失眠症  5-羟色胺  脑源性神经营养因子  食欲素A
收稿时间:2019-07-28

Clinical study on Ciwujia Naoling Solution combined with zaleplon in treatment of insomnia
ZHONG Xiao-bo,FAN Jie and CAO Shui-qin. Clinical study on Ciwujia Naoling Solution combined with zaleplon in treatment of insomnia[J]. Drugs & Clinic, 2020, 35(2): 263-266
Authors:ZHONG Xiao-bo  FAN Jie  CAO Shui-qin
Affiliation:Department of Psychiatry, Chengdu Fourth People''s Hospital, Chengdu 610036, China,Department of Psychiatry, Chengdu Fourth People''s Hospital, Chengdu 610036, China and Department of Psychiatry, Chengdu Fourth People''s Hospital, Chengdu 610036, China
Abstract:Objective To explore the clinical efficacy of Ciwujia Naoling Solution combined with zaleplon in treatment of insomnia. Methods Patients(86 cases) with insomnia in Chengdu Fourth People’s Hospital from February 2018 to February 2019 were divided into control(43 cases) and treatment(43 cases) groups based on different treatments. Patients in the control group were po administered with Zaleplon Tablets, 5 mg/time, once daily. Patients in the treatment group were po administered with Ciwujia Naoling Solution on the basis of the control group, 10 mL/time, twice daily. Patients in two groups were treated for 10 d. After treatment, the clinical efficacy was evaluated, and the PSQI, AIS, PHQ-9, WEMWBS and QLQ-C30 scores, sleep quality, and serum levels of 5-HT, BDNF, IL-1β, Orexin-A, TNF-α and IL-2 in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control group was 81.40%, which was significantly lower than 97.67% in the treatment group, and there were differences between two groups(P<0.05). After treatment, the PSQI, AIS, and PHQ-9 scores in two groups were significantly decreased(P<0.05), but WEMWBS and QLQ-C30 scores were significantly increased(P<0.05), and these scores in the treatment group were significantly better than those in the control group(P<0.05). After treatment, the total sleep time, sleep time of REM, and sleep efficiency in two groups were significantly increased(P<0.05), but sleep latency and wake-up time were significantly decreased(P<0.05), and these indexes in the treatment group were significantly better than those in the control group(P<0.05). After treatment, the serum levels of 5-HT and BDNF in two groups were significantly increased(P<0.05), but the IL-1β, Orexin-A, TNF-α and IL-2 levels were significantly decreased(P<0.05), and these serological indexes in the treatment group were significantly better than those in the control group(P<0.05). Conclusion Ciwujia Naoling Solution combined with zaleplon in treatment of insomnia can significantly improve sleep, improve quality of life, anxiety, depression and mental health.
Keywords:Ciwujia Naoling Solution  Zaleplon Tablets  insomnia  5-HT  BDNF  Orexin-A
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号